The Detectability and Localization Accuracy of Implanted Fiducial Markers Determined on In-Room Computerized Tomography (CT) and Electronic Portal Images (EPI)

Medical Dosimetry

Volumn 33, Issue 3, 2008, Pages 226-233

  Owen, Rebecca ^a   Kron, Tomas ^a   Foroudi, Farshad ^a   Cox, Jennifer ^a   Zhu, Li ^a   Cramb, Jim ^a   Sparks, Laura ^a   Duchesne, Gillian ^a  

^a Radiation Therapy Services   (Australia)

Author keywords

Electronic portal imaging; Gold fiducial markers; Image guided radiation therapy; In room CT

Indexed keywords

GOLD;

ACCURACY; ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; IMAGING SYSTEM; INTERMETHOD COMPARISON; PRIORITY JOURNAL;

BODY WEIGHTS AND MEASURES; GOLD; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; PHANTOMS, IMAGING; PROSTATIC NEOPLASMS; PROSTHESES AND IMPLANTS; RADIOTHERAPY, COMPUTER-ASSISTED; REFERENCE STANDARDS; SIGNAL PROCESSING, COMPUTER-ASSISTED; TECHNOLOGY, RADIOLOGIC; TELEVISION; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 48149095998     PISSN: 09583947     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meddos.2007.12.002     Document Type: Article

References (16)

1. Australian Institute of Health and Welfare (AIHW) and Australasian Association of Cancer Registries. Cancer in Australia 2001 (2004), AIHW, Canberra 1-157
2. van der Heide U.A., Kotte A.N.T.J., Dehnad H., et al. Analysis of fiducial marker-based position verification in the external beam radiotherapy of patients with prostate cancer. Radiother. Oncol. 82 (2007) 38-45
3. Chung P.W.M., Haycocks T., Brown T., et al. On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 60 (2004) 329-334
4. Wu J., Haycocks T., Alasti H., et al. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother. Oncol. 61 (2001) 127-133
5. Dehnad H., Nederveen A.J., van der Heide U.A., et al. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother. Oncol. 67 (2003) 295-302
6. Kitamura K., Shirato H., Shimizu S., et al. Migration of the internal fiducial gold marker implanted into prostate and liver treated with real-time tumor-tracking radiation treatment (RTRT). Int. J. Radiat. Oncol. Biol. Phys. 48 Suppl 1 (2000) 343-344
7. Kupelian P.A., Willoughby T.R., Meeks S.L., et al. Intraprostatic fiducials for localization of the prostate gland: Monitoring intermarker distances during radiation therapy to test for marker stability. Int. J. Radiat. Oncol. Biol. Phys. 62 (2005) 1291-1296
8. Pouliot J., Aubin M., Langen K.M., et al. (Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device. Int. J. Radiat. Oncol. Biol. Phys. 56 (2003) 862-866
9. Litzenberg D., Dawson L.A., Sandler H., et al. Daily prostate targeting using implanted radiopaque markers. Int. J. Radiat. Oncol. Biol. Phys. 52 (2002) 699-703
10. Crook J.M., Raymond Y., Salhani D., et al. Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother. Oncol. 37 (1995) 35-42
11. Schallenkamp J.M., Herman M.G., Kruse J.J., et al. Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging. Int. J. Radiat. Oncol. Biol. Phys. 63 (2005) 800-811
12. Henry A.M., Stratford J., Davies J., et al. An assessment of clinically optimal gold marker length and diameter for pelvic radiotherapy verification using an amorphous silicon flat panel electronic portal imaging device. Br. J. Radiol. 78 (2005) 737-741
13. Siemens Medical Solutions USA, Inc. Optivue 500 and Optivue 1000ST Fully Automated Patient Positioning Systems-Specifications (2006)
14. Kitamura K., Shirato H., Shimizu S., et al. Registration accuracy and possible migration of internal fiducial gold marker implanted in prostate and liver treated with real-time tumor-tracking radiation therapy (RTRT). Radiother. Oncol. 62 (2002) 275-281
15. Moseley D.J., White E.A., Wiltshire K.L., et al. Comparison of localisation performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 67 (2007) 942-953
16. Pollack A., Hanlon A.L., Horwitz E.M., et al. Prostate cancer radiotherapy dose response: An update of the Fox Chase Experience. J. Urol. 171 (2004) 1132-1136